Parveen Shiraz

Suggest Changes
Learn More
PURPOSE To determine the invasive recurrence (IR) risk among patients with small, node-negative human epidermal growth factor receptor 2 (HER2) -positive breast cancer. PATIENTS AND METHODS Among(More)
551 Background: T1abN0M0 BC has a low recurrence risk. In contrast, HER2+ BC has an increased risk of local/distant recurrence. In small case series of T1abN0M0 HER2+ BCs from tertiary referral(More)
  • 1